Literature DB >> 8757867

Translocation of Shiga toxin across polarized intestinal cells in tissue culture.

D W Acheson1, R Moore, S De Breucker, L Lincicome, M Jacewicz, E Skutelsky, G T Keusch.   

Abstract

Escherichia coli strains producing Shiga toxins (Stx) 1 and 2 colonize the lower gastrointestinal tract in humans and are associated with gastrointestinal and systemic diseases. Stx are detectable in the feces of infected patients, and it is likely that toxin passes from the intestinal tract lumen to underlying tissues. The objective of this study was to develop an in vitro model to study the passage of Stx across intact, polarized cell monolayers. Translocation of biologically active Stx was examined in four cell lines grown on polycarbonate filters. Stx1 translocated across intestinal cell monolayers (CaCo2A and T84 cells) in an energy-requiring and saturable manner, while the monolayers maintained a high level of electrical resistance. Stx1 had no effect on electrical resistance or inulin movement across these cell lines for at least 24 h. Induction of specific Stx receptors with sodium butyrate reduced the proportion of toxin translocated across CaCo2A monolayers but had no major effect on the movement of horseradish peroxidase or [3H]inulin. We have shown that biologically active Stx1 is capable of moving across intact polarized intestinal epithelial cells without apparent cellular disruption, probably via a transcellular pathway. The data also suggest that the presence of Stx receptors on the apical surface of intestinal epithelial cells may offer some protection against the absorption of luminal Stx1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757867      PMCID: PMC174221          DOI: 10.1128/iai.64.8.3294-3300.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

2.  Pathogenesis of haemolytic uraemic syndrome.

Authors:  T G Obrig; P J Del Vecchio; M A Karmali; M Petric; T P Moran; T K Judge
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

3.  Transcytosis of cholera toxin subunits across model human intestinal epithelia.

Authors:  W I Lencer; S Moe; P A Rufo; J L Madara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

Authors:  S E Richardson; M A Karmali; L E Becker; C R Smith
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

5.  Primary amines and chloroquine inhibit cytotoxic responses to Shigella toxin and permit late antibody rescue of toxin treated cells.

Authors:  G T Keusch; M Jacewicz
Journal:  Biochem Biophys Res Commun       Date:  1984-05-31       Impact factor: 3.575

6.  A human colonic tumor cell line that maintains vectorial electrolyte transport.

Authors:  K Dharmsathaphorn; J A McRoberts; K G Mandel; L D Tisdale; H Masui
Journal:  Am J Physiol       Date:  1984-02

7.  Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction.

Authors:  J L Madara; R Moore; S Carlson
Journal:  Am J Physiol       Date:  1987-12

8.  Manifold effects of sodium butyrate on nuclear function. Selective and reversible inhibition of phosphorylation of histones H1 and H2A and impaired methylation of lysine and arginine residues in nuclear protein fractions.

Authors:  L C Boffa; R J Gruss; V G Allfrey
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

View more
  48 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Effect of Shiga toxin 2 on water and ion transport in human colon in vitro.

Authors:  P Fiorito; J M Burgos; M F Miyakawa; M Rivas; G Chillemi; D Berkowski; E Zotta; C Silberstein; C Ibarra
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro.

Authors:  C Menge; L H Wieler; T Schlapp; G Baljer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells.

Authors:  Valeriy Lukyanenko; Irina Malyukova; Ann Hubbard; Michael Delannoy; Edgar Boedeker; Chengru Zhu; Liudmila Cebotaru; Olga Kovbasnjuk
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

5.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

6.  An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Authors:  Miho Watanabe-Takahashi; Toshio Sato; Taeko Dohi; Noriko Noguchi; Fumi Kano; Masayuki Murata; Takashi Hamabata; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

7.  stx1c Is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle.

Authors:  Kim N Brett; Vidiya Ramachandran; Michael A Hornitzky; Karl A Bettelheim; Mark J Walker; Steven P Djordjevic
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

8.  Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Authors:  C M Thorpe; B P Hurley; L L Lincicome; M S Jacewicz; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

9.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

10.  Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.

Authors:  Dong-Oh Moon; Se-Rim Choi; Chang-Min Lee; Gi-Young Kim; Hee-Jeong Lee; Yeong-Min Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.